Pennsylvania Patient Safety Authority Issues Statewide Warning

A state agency born from law and funded by a dedicated trust has flagged two persistent medication hazards — weight documentation failures and unauthorized drug alterations — that keep generating preventable harm across Pennsylvania facilities.

How the Authority Works

Created under Pennsylvania Act 13 of 2002 — formally the Medical Care Availability and Reduction of Error Act, or MCARE Act¹ — the Pennsylvania Patient Safety Authority occupies a distinctive place in the state's health infrastructure. It is neither a licensing board nor an enforcement agency. Its power is informational: facilities are required by law to report adverse events and near-misses, the Authority analyzes those reports for patterns, and the resulting advisories flow back to the Pennsylvania Department of Health ↗ as formal recommendations. Funding runs through the Patient Safety Trust Fund³, a dedicated mechanism that keeps operations independent of year-to-year budget politics.

The model is deliberate. Mandatory incident reporting² means data collection doesn't depend on voluntary disclosure — a chronic weakness of safety systems elsewhere. By aggregating reports statewide, the Authority can detect a pattern that any single hospital might dismiss as an isolated fluke. When that pattern rises to the level of a formal advisory, it carries real institutional weight: facilities and pharmacies across Pennsylvania are expected to act on the guidance.

Two recent advisories illustrate how the mechanism works in practice — and how long-standing vulnerabilities can persist even inside a functioning safety reporting system.

Weight Documentation and Medication Dosing

The first advisory targets weight documentation error⁶s. The link between the two may not be obvious outside clinical settings, but it is direct: dosing calculations for many medications — anticoagulants, chemotherapy agents, pediatric drugs, and others — are calculated on a per-kilogram or per-pound basis. An inaccurate weight means an inaccurate dose.

The Authority identified weight documentation failure as a persistent problem across Pennsylvania facilities, and the numbers behind that finding are substantial.

The Authority identified weight documentation failure as a persistent problem across Pennsylvania facilities, and the numbers behind that finding are substantial. In 2009 alone, the Authority recorded 480 medication error events linked to inaccurate weight documentation. That figure represents reported events — the actual incidence of undocumented or miscalculated weights affecting care is almost certainly higher.

Contributing factors are both logistical and communicative. Some clinical settings simply lack appropriate weighing equipment, meaning staff record an estimated or outdated figure rather than a verified current weight. In other cases, communication barriers — language, cognitive impairment, care transitions between units — prevent clinicians from obtaining a reliable measurement before prescribing begins. The Authority's guidance calls for systematic verification: no dosing calculation should proceed from an unconfirmed weight.

Crushing and Altering Medications

The second advisory addresses a separate but related problem — the unauthorized crushing, splitting, or mixing of medications with food or liquid. Between January 2006 and September 2017, the Authority received 621 reports involving altered or crushed medication doses. The affected population skews older: patients aged 65 and above are disproportionately represented in the data, partly because swallowing difficulties are more common in that group and partly because polypharmacy increases the temptation to combine doses into a single administrable form.

The clinical hazard is real and underappreciated. Many medications carry protective coatings designed to prevent gastric irritation or control where in the digestive tract absorption occurs. Crushing destroys those coatings. Extended-release formulation⁴s are engineered to deliver active ingredients gradually over hours; crushing them releases the full dose at once, with potentially toxic results. The absorption profile⁵ changes, the therapeutic rationale breaks down, and the patient is exposed to risk that the prescriber never intended.

The Authority's recommended response works at two points in the care pathway. At the dispensing stage, facilities and pharmacies are encouraged to provide pre-split tablets or liquid formulations wherever clinically appropriate, eliminating the need for patients or caregivers to modify doses themselves. At the prescribing stage, clinicians are advised to check any crushing or splitting instruction against current formulary guidance⁷ before it reaches the patient.

1. 2002Pennsylvania Act 13 / MCARE Act enacted; Authority established.
2. 2006Start of Authority's crushed/altered medication data collection window.
3. 2009Year of 480 weight-documentation medication error events.
4. September 2017End of crushed/altered medication data collection window.

Pattern Recognition as Public Health

Taken together, the two advisories demonstrate what the Authority's architecture is designed to produce: the conversion of local errors into system-wide learning. A single hospital encountering a weight-documentation error may treat it as a staffing oversight. The same error reported hundreds of times across dozens of facilities reveals a structural failure that no individual institution can fix alone.

That translation — from incident report to statewide advisory — is the Authority's core function, and it depends entirely on the integrity of mandatory reporting. The moment facilities begin underreporting, the pattern disappears and the guidance stops arriving. For Pennsylvania's patient safety infrastructure, the pipeline is only as strong as the honesty flowing into it.